Prolacta Makes Statement on Recent Study Demonstrating Risks of Milk Sharing
Type: Press Releases
Topic(s): Clinical Studies
Prolacta Announces the Opening of a New 67000 Square Foot Facility to Meet Growing Hospital Demand for Exclusive Human Milk Nutrition for Preemies
Type: Press Releases
Topic(s): Company
Study Determines Development of Necrotizing Enterocolitis In Premature Infants Increases Long-Term Healthcare Costs
Type: Press Releases
Topic(s): Cost Savings / Cost Effectiveness Necrotizing Entercolitis (NEC) Total Parenteral Nutrition (TPN) Use
Prolacta Bioscience to Donate the Processing of Nearly 17000 Ounces of Donor Breast Milk for International Breast Milk Project
Type: Press Releases
Topic(s): Company
Prolacta Announces Study Published in Journal of Pediatrics DemonstratesLower Incidence of Intestinal Disease in Preemies Fed Exclusive Human Milk Diet
Type: Press Releases
Topic(s): Clinical Studies Necrotizing Entercolitis (NEC) Total Parenteral Nutrition (TPN) Use
Prolacta Bioscience Announces Donor Breast Milk Supply Program for Preemies in Hospital Neonatal Intensive Care Units
Type: Press Releases
Topic(s): Company Quality & Safety
Independent Data Continues to Mount on Benefits of Human Breast Milk Nutrition for Extremely Premature Infants
Type: Press Releases
Topic(s): Clinical Studies Cost Savings / Cost Effectiveness Necrotizing Entercolitis (NEC)
Prolacta Praises Landmark Legislation in Kentucky Mandating Human Milk Diet for Preemies in Jeopardy of Intestinal Disease
Type: Press Releases
Topic(s): Legislative
Over One Million Dollars Donated to Philanthropic Organizations by Prolacta Bioscience
Type: Press Releases
Topic(s): Company
Not finding the reference you’re looking for?
Use our main search field or email us at info@prolacta.com